Questionnaire survey on the prescribing practice of Japanese psychiatrists for mood disorders

Akihiko Oshima, Teruhiko Higuchi, Yutaka Fujiwara, Makoto Iida, Akira Iwanami, Shigenobu Kanba, Nobutaka Motohashi, Yosuke Uchitomi, Kazuo Yamada, Shigeto Yamawaki

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The answers to a questionnaire on the practical prescription in mood disorders from 298 Japanese psychiatrists was obtained. As the first-line treatment, a majority of respondents chose newer tricyclic agents (TCA) or non-TCA for moderate depression and older TCA for severe depression both with and without psychotic features. Combination therapy with antidepressants and anxiolytics was fairly popular in moderate depression, while antidepressant/neuroleptic combination was more common in severe psychotic depression. Sulpiride was the most favored drug for dysthymia. Although lithium was the most popular for bipolar mania, respondents were divided on the treatment of bipolar depression.

Original languageEnglish
JournalPsychiatry and Clinical Neurosciences
Volume53
Issue numberSUPPL.
Publication statusPublished - Oct 1 1999

Fingerprint

Mood Disorders
Psychiatry
Depression
Bipolar Disorder
Antidepressive Agents
Sulpiride
Anti-Anxiety Agents
Lithium
Antipsychotic Agents
Prescriptions
Surveys and Questionnaires
Pharmaceutical Preparations
Therapeutics

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

Oshima, A., Higuchi, T., Fujiwara, Y., Iida, M., Iwanami, A., Kanba, S., ... Yamawaki, S. (1999). Questionnaire survey on the prescribing practice of Japanese psychiatrists for mood disorders. Psychiatry and Clinical Neurosciences, 53(SUPPL.).

Questionnaire survey on the prescribing practice of Japanese psychiatrists for mood disorders. / Oshima, Akihiko; Higuchi, Teruhiko; Fujiwara, Yutaka; Iida, Makoto; Iwanami, Akira; Kanba, Shigenobu; Motohashi, Nobutaka; Uchitomi, Yosuke; Yamada, Kazuo; Yamawaki, Shigeto.

In: Psychiatry and Clinical Neurosciences, Vol. 53, No. SUPPL., 01.10.1999.

Research output: Contribution to journalArticle

Oshima, A, Higuchi, T, Fujiwara, Y, Iida, M, Iwanami, A, Kanba, S, Motohashi, N, Uchitomi, Y, Yamada, K & Yamawaki, S 1999, 'Questionnaire survey on the prescribing practice of Japanese psychiatrists for mood disorders', Psychiatry and Clinical Neurosciences, vol. 53, no. SUPPL..
Oshima A, Higuchi T, Fujiwara Y, Iida M, Iwanami A, Kanba S et al. Questionnaire survey on the prescribing practice of Japanese psychiatrists for mood disorders. Psychiatry and Clinical Neurosciences. 1999 Oct 1;53(SUPPL.).
Oshima, Akihiko ; Higuchi, Teruhiko ; Fujiwara, Yutaka ; Iida, Makoto ; Iwanami, Akira ; Kanba, Shigenobu ; Motohashi, Nobutaka ; Uchitomi, Yosuke ; Yamada, Kazuo ; Yamawaki, Shigeto. / Questionnaire survey on the prescribing practice of Japanese psychiatrists for mood disorders. In: Psychiatry and Clinical Neurosciences. 1999 ; Vol. 53, No. SUPPL.
@article{d1f583f3834545ba84db6f50675e4810,
title = "Questionnaire survey on the prescribing practice of Japanese psychiatrists for mood disorders",
abstract = "The answers to a questionnaire on the practical prescription in mood disorders from 298 Japanese psychiatrists was obtained. As the first-line treatment, a majority of respondents chose newer tricyclic agents (TCA) or non-TCA for moderate depression and older TCA for severe depression both with and without psychotic features. Combination therapy with antidepressants and anxiolytics was fairly popular in moderate depression, while antidepressant/neuroleptic combination was more common in severe psychotic depression. Sulpiride was the most favored drug for dysthymia. Although lithium was the most popular for bipolar mania, respondents were divided on the treatment of bipolar depression.",
author = "Akihiko Oshima and Teruhiko Higuchi and Yutaka Fujiwara and Makoto Iida and Akira Iwanami and Shigenobu Kanba and Nobutaka Motohashi and Yosuke Uchitomi and Kazuo Yamada and Shigeto Yamawaki",
year = "1999",
month = "10",
day = "1",
language = "English",
volume = "53",
journal = "Psychiatry and Clinical Neurosciences",
issn = "1323-1316",
publisher = "Wiley-Blackwell",
number = "SUPPL.",

}

TY - JOUR

T1 - Questionnaire survey on the prescribing practice of Japanese psychiatrists for mood disorders

AU - Oshima, Akihiko

AU - Higuchi, Teruhiko

AU - Fujiwara, Yutaka

AU - Iida, Makoto

AU - Iwanami, Akira

AU - Kanba, Shigenobu

AU - Motohashi, Nobutaka

AU - Uchitomi, Yosuke

AU - Yamada, Kazuo

AU - Yamawaki, Shigeto

PY - 1999/10/1

Y1 - 1999/10/1

N2 - The answers to a questionnaire on the practical prescription in mood disorders from 298 Japanese psychiatrists was obtained. As the first-line treatment, a majority of respondents chose newer tricyclic agents (TCA) or non-TCA for moderate depression and older TCA for severe depression both with and without psychotic features. Combination therapy with antidepressants and anxiolytics was fairly popular in moderate depression, while antidepressant/neuroleptic combination was more common in severe psychotic depression. Sulpiride was the most favored drug for dysthymia. Although lithium was the most popular for bipolar mania, respondents were divided on the treatment of bipolar depression.

AB - The answers to a questionnaire on the practical prescription in mood disorders from 298 Japanese psychiatrists was obtained. As the first-line treatment, a majority of respondents chose newer tricyclic agents (TCA) or non-TCA for moderate depression and older TCA for severe depression both with and without psychotic features. Combination therapy with antidepressants and anxiolytics was fairly popular in moderate depression, while antidepressant/neuroleptic combination was more common in severe psychotic depression. Sulpiride was the most favored drug for dysthymia. Although lithium was the most popular for bipolar mania, respondents were divided on the treatment of bipolar depression.

UR - http://www.scopus.com/inward/record.url?scp=0032704545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032704545&partnerID=8YFLogxK

M3 - Article

C2 - 10560902

AN - SCOPUS:0032704545

VL - 53

JO - Psychiatry and Clinical Neurosciences

JF - Psychiatry and Clinical Neurosciences

SN - 1323-1316

IS - SUPPL.

ER -